These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31925592)

  • 1. Updated guidelines for intravenous contrast use for CT and MRI.
    Huynh K; Baghdanian AH; Baghdanian AA; Sun DS; Kolli KP; Zagoria RJ
    Emerg Radiol; 2020 Apr; 27(2):115-126. PubMed ID: 31925592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of magnetic resonance contrast media.
    Runge VM
    Top Magn Reson Imaging; 2001 Aug; 12(4):309-14. PubMed ID: 11687717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contrast agents in MRT. Substance, effects, pharmacology and validity].
    Reimer P; Vosshenrich R
    Radiologe; 2004 Mar; 44(3):273-83. PubMed ID: 15287365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions.
    Maloney E; Iyer RS; Phillips GS; Menon S; Lee JJ; Callahan MJ
    Pediatr Radiol; 2019 Apr; 49(4):433-447. PubMed ID: 30923875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
    McDonald JS; Hunt CH; Kolbe AB; Schmitz JJ; Hartman RP; Maddox DE; Kallmes DF; McDonald RJ
    Radiology; 2019 Sep; 292(3):620-627. PubMed ID: 31264948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors.
    Murphy KP; Szopinski KT; Cohan RH; Mermillod B; Ellis JH
    Acad Radiol; 1999 Nov; 6(11):656-64. PubMed ID: 10894068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of approved MR contrast media for intravenous injection.
    Runge VM
    J Magn Reson Imaging; 2000 Aug; 12(2):205-13. PubMed ID: 10931582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute adverse reactions to magnetic resonance contrast media--gadolinium chelates.
    Li A; Wong CS; Wong MK; Lee CM; Au Yeung MC
    Br J Radiol; 2006 May; 79(941):368-71. PubMed ID: 16632615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use and Safety of Gadolinium Based Contrast Agents in Pediatric MR Imaging.
    Holowka S; Shroff M; Chavhan GB
    Indian J Pediatr; 2019 Oct; 86(10):961-966. PubMed ID: 30796704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to Reduce the Use of Gadolinium-Based Contrast Agents for Abdominal MRI in Children.
    Anderson MA; Harrington SG; Kozak BM; Gee MS
    AJR Am J Roentgenol; 2020 May; 214(5):1054-1064. PubMed ID: 32097030
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in adverse events after IV administration of contrast media.
    Cochran ST; Bomyea K; Sayre JW
    AJR Am J Roentgenol; 2001 Jun; 176(6):1385-8. PubMed ID: 11373197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents.
    Hojreh A; Peyrl A; Bundalo A; Szepfalusi Z
    PLoS One; 2020; 15(4):e0230781. PubMed ID: 32243440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of iodinated contrast allergies on emergency department operations.
    Berlyand Y; Fraga JA; Succi MD; Yun BJ; Lee AH; Baugh JJ; Whitehead D; Raja AS; Prabhakar AM
    Am J Emerg Med; 2022 Nov; 61():127-130. PubMed ID: 36096014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic-like breakthrough reactions to gadolinium contrast agents after corticosteroid and antihistamine premedication.
    Dillman JR; Ellis JH; Cohan RH; Strouse PJ; Jan SC
    AJR Am J Roentgenol; 2008 Jan; 190(1):187-90. PubMed ID: 18094310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of intravenous contrast material use and corticosteroid premedication in children--a survey of Society of Chairs of Radiology in Children's Hospitals (SCORCH) member institutions.
    Trout AT; Dillman JR; Ellis JH; Cohan RH; Strouse PJ
    Pediatr Radiol; 2011 Oct; 41(10):1272-83. PubMed ID: 21594547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know.
    Rose TA; Choi JW
    Am J Med; 2015 Sep; 128(9):943-9. PubMed ID: 25820169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute adverse reactions to radiographic iodinated and gadolinium-based contrast media: incidence, risk factors and premedication: from published evidence to a practical approach.
    Tonolini M; Bianco R
    Clin Ter; 2011; 162(6):591-4. PubMed ID: 22262334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol.
    Jingu A; Fukuda J; Taketomi-Takahashi A; Tsushima Y
    BMC Med Imaging; 2014 Oct; 14():34. PubMed ID: 25287952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN; Francis IR
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium-based contrast agents - review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients.
    Blumfield E; Swenson DW; Iyer RS; Stanescu AL
    Pediatr Radiol; 2019 Apr; 49(4):448-457. PubMed ID: 30923876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.